Meet Adam - CFO of Renew Biotechnologies - Diagnostic Innovation Reimagined

In this episode of the Growth Mindset podcast, Coach Dave March interviews Adam Hewlett, CFO of Renew Biotechnologies, discussing innovative diagnostic technologies aimed at improving early detection of neurodegenerative diseases such as Alzheimer's, ALS, and Parkinson's. They explore the importance of proactive health management, the role of epigenetics, and the challenges faced in the field of neurodegenerative disease management. Adam shares insights on the Resonant Assay, a groundbreaking test designed to diagnose these conditions before symptoms appear, emphasizing the need for early intervention to enhance quality of life.

Key Takeaways:

• The Growth Mindset podcast focuses on innovative ideas and technologies.
• Renew Biotechnologies aims to improve precision diagnostics and personalized care.
• The Resonant Assay helps diagnose neurodegenerative diseases from a simple blood draw.
• Early detection can occur five to seven years before symptoms appear.
• Proactive health management is essential for improving quality of life.
• Trends in preventative medicine emphasize early detection and personalized treatment plans.
• Epigenetics plays a crucial role in understanding genetic expression and disease.
• There is significant investment in research for neurodegenerative disease cures.
• Catching diseases early can lead to better management and outcomes.
• The goal is to impact millions of lives positively through innovative diagnostics.

Chapters:

 

00:00Introduction to Growth Mindset Podcast

00:53Innovations in Diagnostic Technologies

02:19The Resonant Assay: Early Detection of Neurodegenerative Diseases

05:35Proactive Health Management and Quality of Life

08:43Trends in Preventative Medicine

11:22Understanding Epigenetics and Its Implications

15:36Challenges in Neurodegenerative Disease Management

19:46Conclusion and Contact Information